• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.29% Nasdaq Up1.40%

    MELA Sciences, Inc. (MELA)

    -NasdaqCM
    1.29 Down 0.04(2.95%) 10:35AM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    MELA Sciences, Inc.
    50 South Buckhout Street
    Suite 1
    Irvington, NY 10533
    United States - Map
    Phone: 914-591-3783
    Fax: 914-591-3785
    Website: http://www.melasciences.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:45

    Business Summary 

    MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma. The company’s principal product, MelaFind, consists of a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions, which is then analyzed utilizing classification algorithms trained on its proprietary database of melanomas and benign lesions to provide information to assist in the management of the patient’s disease, including information useful in the decision of whether to biopsy the lesion. MELA Sciences, Inc. offers its product to dermatologists. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MELA Sciences, Inc.

    Key Executives 
     PayExercised
    Mr. Jeffrey Francis O'Donnell Sr., 54
    Exec. Chairman and Member of Compensation Committee
    N/AN/A
    Mr. Robert W. Cook , 58
    Chief Financial Officer, Sec. and Treasurer
    N/AN/A
    Jeffery Wallace ,
    Sr. VP of Devel. and Innovation
    N/AN/A
    Dr. Dina Gutkowicz-Krusin Ph.D.,
    Director of Clinical Studies
    N/AN/A
    Mr. Nikolai Kabelev , 38
    VP of R&D
    190.00K0.00
    Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders